Biodesix Inc SEC filings BDSX

Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 9, 2026 —
DEF 14A Proxy statement Apr 9, 2026 May 19, 2026
DEF 14A Proxy statement Apr 28, 2025 May 20, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 May 20, 2025
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 May 21, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 May 21, 2024
DEFA14A Additional proxy material Apr 12, 2023 —
DEF 14A Proxy statement Apr 12, 2023 May 23, 2023
PRE 14A Preliminary proxy statement Mar 31, 2023 May 23, 2023
DEFA14A Additional proxy material Mar 31, 2022 —
DEF 14A Proxy statement Mar 31, 2022 May 24, 2022
DEF 14A Proxy statement Apr 29, 2021 May 26, 2021

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BDSX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Louisville, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1439725

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.